Preventive cardiology researchers at UT Southwestern Medical Center have been on a mission to look for new ways to detect early stage heart disease in people who are not currently in treatment. They now believe that a new blood test for protein biomarkers could...
The North American Menopause Society (NAMS) completed the VITamin D and OmegA-3 Trial (VITAL)., the largest and most recent test to investigate Vitamin D or fish oil can effectively prevent cancer or cardiovascular disease. Results have been generally mixed however in...
Yale Department of Neurology received a $4 million grant from the National Institutes of Health to assess acute ischemic stroke treatments in rodent models. They are participating with other institutions in the Stroke Preclinical Assessment Network or SPAN. The...
The COMPASS trial revealed that patients with stable atherosclerotic vascular disease tremendously benefit from 2.5 mg Xarelto twice daily, plus 100 mg aspirin once daily. This regimen was found to have not only reduced the risk of a second cardiovascular event (e.g.,...
A Kaiser Permanente Northern California-led large observational study reveals that achieving very low levels of low-density lipoprotein (LDL) cholesterol while on statin treatment may reduce the risk of cardiovascular disease (CVD) in people with type 2 diabetes and...
The University of Buffalo along with collaborators have provided pathophysiologic evidence that air pollution impacts cardiovascular disease in China. In fact, the findings suggest that China may need to revise its standard for one type of pollutant. Published in JAMA...
